Retinoschisin (RS) is a 24 kDa secreted protein expressed in retina and is required for the structural and functional integrity of the retina. RS has been predicted to serve as an adhesive protein but the precise molecular mechanism by which it functions in retina is not yet known. During investigations on structural and functional aspects of RS in murine retina using proteomic tools, we identified two isoforms of RS that differed in mass by 200 Da with no apparent change in charge. Mass spectra and amino acid sequence analysis of the tryptic peptides revealed that these isoforms differed by two amino acids at the N-terminus which suggested processing of RS signal sequence at two cleavage sites by signal peptidase as the basic mechanism underlying the occurrence of two mature RS isoforms in retina. Bioinformatic analysis identified two potential cleavage sites (between amino acids 21-22 and 23-24) in RS signal sequence. The flexibility of the signal peptidase to cleave at two sites is correlated to the amino acid composition of the RS signal sequence. This finding represents a rare example of a naturally occurring signal sequence cleavage at more than one site in vivo.
KeywordsRetina; Retinoschisin; Post-Translational Modifications; Isoforms; Signal Sequence; Signal peptidase; Processing; X-linked retinoschisis; Missense mutations Retinoschisin (RS) is a 24 kDa secreted protein expressed in retina and pineal * and is required for the structural and functional integrity of the retina [1]. Based on its conserved discoidin domain sequence, RS is predicted to serve as an adhesion protein in maintaining the organization of the retina [1] but a precise molecular description of RS function is not yet known. Mutations in the RS1 gene that encodes the RS protein cause monogenic X-linked retinoschisis (XLRS) in young males [2][3][4]. Retinoschisis is a form of juvenile macular Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errorsmaybe discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. * Takada et. al.(2006
NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript degeneration in which schisis or splitting within the nuclear and plexiform layers of the retina [5] leads to progressive loss of vision beginning at a young age [6]. Gene therapy is being considered as a therapeutic approach to treat XLRS disease which otherwise has no known cure [7].RS is synthesized in retinal photoreceptor, bipolar amacrine and ganglion cells [8,9]. The 224 amino acid RS polypeptide consists of a 23 amino acid leader sequence followed by a 39 amino acid RS domain, a highly conserved 157 amino acid discoidin domain and a 5 amino acid Ctermin...